Newly (2018) Approved Drugs by FDA

Author Topic: Newly (2018) Approved Drugs by FDA  (Read 198 times)

Offline tahmina

  • Jr. Member
  • **
  • Posts: 76
  • Test
    • View Profile
Newly (2018) Approved Drugs by FDA
« on: April 28, 2018, 04:01:15 PM »
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. Review descriptions for our medical therapeutic area list to help assist in your search.
Join our Drug Research Updates group on LinkedIn!

Find out more about the types of drugs included in this listing.


Dermatology
Ilumya (tildrakizumab-asmn); Sun Pharmaceuticals; For the treatment of plaque psoriasis , Approved March 2018

Gastroenterology
Lutathera (lutetium Lu 177 dotatate); Advanced Accelerator Applications; For the treatment of gastroenteropancreatic neuroendocrine tumors, Approved January 2018

Immunology
Ilumya (tildrakizumab-asmn); Sun Pharmaceuticals; For the treatment of plaque psoriasis , Approved March 2018

Infections and Infectious Diseases
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide); Gilead; For the treatment of HIV-1 infection in adults, Approved February 2018
Trogarzo (ibalizumab-uiyk); TaiMed Biologics; For the treatment of multidrug resistant HIV-1 infection, Approved March 2018

Oncology
Erleada (apalutamide); Janssen Oncology; For the treatment of prostate cancer, Approved February 2018

Lutathera (lutetium Lu 177 dotatate); Advanced Accelerator Applications; For the treatment of gastroenteropancreatic neuroendocrine tumors, Approved January 2018
Pulmonary/Respiratory Diseases
Symdeko (tezacaftor/ivacaftor) ; Vertex; For the treatment of cystic fibrosis , Approved February 2018
Urology
Erleada (apalutamide); Janssen Oncology; For the treatment of prostate cancer, Approved February 2018

Source: https://www.centerwatch.com/drug-information/fda-appr